Peter Attia· MD
and predator prey models are still are things that we use a little bit like for the immune system where the immune system is kind of a predator and the and it's chasing after the the cancer cells
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and predator prey models are still are things that we use a little bit like for the immune system where the immune system is kind of a predator and the and it's chasing after the the cancer cells
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and predator prey models are still are things that we use a little bit like for the immune system where the immune system is kind of a predator and the and it's chasing after the the cancer cells but of course there's there's important differences in that the the uh predator eats the prey and gains you know substrate from that whereas in in the pre in the immune system it kills the the cancer cells but it loses substrate doesn't eat them up and in fact if anybody's eating anything it's probably the cancer cells are swooping up uh you know elements of their brethren that you know the macromolecules that they're getting spilled into the environment so so there's it again it's one of those things that's an appealing model the predator prey model in in immunotherapy and yet there are important distinctions that you have to recognize that that make the biology different and in some ways can give advantages to the prey that you don't really expect